AP2008004448A0 - Plasmodium liver stage antigens - Google Patents

Plasmodium liver stage antigens

Info

Publication number
AP2008004448A0
AP2008004448A0 AP2008004448A AP2008004448A AP2008004448A0 AP 2008004448 A0 AP2008004448 A0 AP 2008004448A0 AP 2008004448 A AP2008004448 A AP 2008004448A AP 2008004448 A AP2008004448 A AP 2008004448A AP 2008004448 A0 AP2008004448 A0 AP 2008004448A0
Authority
AP
ARIPO
Prior art keywords
liver stage
stage antigens
plasmodium liver
plasmodium
antigens
Prior art date
Application number
AP2008004448A
Other languages
English (en)
Inventor
Lawrence W Bergman
Patrick Duffy
Stefan H I Et Al Kappe
Original Assignee
Seattle Biomedical Res Inst
Reed Army Inst Research
Philadelphia Health & Educatio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seattle Biomedical Res Inst, Reed Army Inst Research, Philadelphia Health & Educatio filed Critical Seattle Biomedical Res Inst
Publication of AP2008004448A0 publication Critical patent/AP2008004448A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AP2008004448A 2005-09-30 2006-09-29 Plasmodium liver stage antigens AP2008004448A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72225405P 2005-09-30 2005-09-30
US74838205P 2005-12-08 2005-12-08
PCT/US2006/037851 WO2007041216A2 (en) 2005-09-30 2006-09-29 Plasmodium liver stage antigens

Publications (1)

Publication Number Publication Date
AP2008004448A0 true AP2008004448A0 (en) 2008-04-30

Family

ID=37592456

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004448A AP2008004448A0 (en) 2005-09-30 2006-09-29 Plasmodium liver stage antigens

Country Status (7)

Country Link
US (2) US7722889B2 (pt)
EP (2) EP2264058A3 (pt)
AP (1) AP2008004448A0 (pt)
AT (1) ATE476444T1 (pt)
BR (1) BRPI0616602A2 (pt)
DE (1) DE602006015985D1 (pt)
WO (1) WO2007041216A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI477602B (zh) * 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
US9333249B2 (en) * 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
EP2163627A1 (en) 2008-09-12 2010-03-17 Bernhard-Nocht-Institut für Tropenmedizin Attenuated liver-stage Plasmodium and vaccin containing the same
US20110229514A1 (en) * 2009-03-16 2011-09-22 Denise Doolan Vaccine and immunization method using plasmodium antigen 2
CA3002946C (en) * 2009-11-05 2021-11-02 The United States Of America As Represented By The Secretary Of The Navy Plasmodium falciparum sporozoite and liver stage antigens
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
WO2014075047A2 (en) * 2012-11-12 2014-05-15 Genvec, Inc. Malaria antigens and methods of use
WO2014084333A1 (ja) * 2012-11-30 2014-06-05 国立大学法人三重大学 マラリア原虫肝臓ステージの感染に関わる原虫蛋白質
EP2923709A1 (en) * 2014-03-28 2015-09-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Multi-component-multistage malaria vaccine
EP2992895A1 (en) 2014-09-08 2016-03-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Three-component-multistage malaria vaccine
EP3081575A1 (en) 2015-04-12 2016-10-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anti-plasmodium parasite antibodies
DE102015210919A1 (de) 2015-06-15 2016-12-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. MEMS-Wandler zum Interagieren mit einem Volumenstrom eines Fluids und Verfahren zum Herstellen desselben
US12544441B2 (en) 2016-11-01 2026-02-10 Washington University Compositions comprising CelTOS immunogens and antibodies and method of use thereof
US12398184B2 (en) 2016-11-01 2025-08-26 Washington University Compositions comprising CelTOS immunogens and antibodies and method of use thereof
EP3600399A4 (en) * 2017-03-30 2021-03-24 The United States of America, as represented by the Secretary of the Navy PROCEDURES AND COMPOSITIONS FOR VACCINATION AGAINST MALARIA
WO2018193063A2 (en) 2017-04-19 2018-10-25 Institute For Research In Biomedicine Novel malaria vaccines and antibodies binding to plasmodium sporozoites
DE102017206766A1 (de) 2017-04-21 2018-10-25 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Mems-wandler zum interagieren mit einem volumenstrom eines fluids und verfahren zum herstellen desselben

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4372945A (en) 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
IL61904A (en) 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5288707A (en) 1990-08-13 1994-02-22 Sandoz Ltd. Borolysine peptidomimetics
GB9020438D0 (en) 1990-09-19 1990-10-31 Imperial College Plasmodium liver stage antigens
US5552534A (en) 1991-08-22 1996-09-03 The Trustees Of The University Of Pennsylvania Non-Peptide peptidomimetics
US5550251A (en) 1991-12-12 1996-08-27 The Trustees Of The University Of Pennsylvania Alicyclic peptidomimetics
US5821231A (en) 1993-12-06 1998-10-13 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using same
IL109943A (en) 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US5817626A (en) 1995-03-14 1998-10-06 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation
US5811515A (en) 1995-06-12 1998-09-22 California Institute Of Technology Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis
US20030133944A1 (en) 2001-04-05 2003-07-17 Smithkline Beecham Biologicals S.A. Vaccine composition against malaria
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1212423B1 (en) 1999-09-01 2009-01-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a
US7029685B2 (en) 2001-03-26 2006-04-18 The United States Of America As Represented By The Secretary Of The Army Plasmodium falciparum AMA-1 protein and uses thereof
US7078507B2 (en) 2001-11-09 2006-07-18 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Synthetic genes for malarial proteins and methods of use
US7718165B2 (en) 2003-12-19 2010-05-18 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine

Also Published As

Publication number Publication date
EP2264058A2 (en) 2010-12-22
DE602006015985D1 (de) 2010-09-16
US8318183B2 (en) 2012-11-27
EP1937715B1 (en) 2010-08-04
US20100166794A1 (en) 2010-07-01
ATE476444T1 (de) 2010-08-15
WO2007041216A2 (en) 2007-04-12
BRPI0616602A2 (pt) 2011-06-28
EP2264058A3 (en) 2011-03-23
EP1937715A2 (en) 2008-07-02
WO2007041216A3 (en) 2007-08-02
US7722889B2 (en) 2010-05-25
US20090017055A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
HUS1900050I1 (hu) Konstruált anti-IL-23 antitestek
IL187106A (en) Sclerostin binds antibody
IL190472A0 (en) Anti-glypican-3 antibody
IL192266A0 (en) Anti-ilt7 antibody
EP1927118A4 (en) MAGNETIC CONSTITUENTS
EP1913543A4 (en) ADVERTISING ALLOCATION PERFORMED IN ACCORDANCE WITH THE BUDGET
IL185366A0 (en) Antibody
AP2008004448A0 (en) Plasmodium liver stage antigens
GB0517487D0 (en) Antibodies
DE602006006079D1 (en) Ren
ZA200803550B (en) Plasmodium liver stage antigens
EP1834123A4 (en) FLANGE
EP1896047A4 (en) ANTI-GFRALPHA3 ANTIBODIES
EP1820615A4 (en) MECHANICAL RABOT
GB0505489D0 (en) Antibodies
GB2412690B (en) Arrangements for joining members together
GB2433075B (en) Auditorium
GB0513123D0 (en) Artificial liver
GB0501106D0 (en) Sign studio
GB0512278D0 (en) Antibodies
GB0505054D0 (en) Antibodies
GB0502001D0 (en) Catches
PL115597U1 (en) Medallion
GB0519883D0 (en) Antibodies
AU305522S (en) Flange